Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer

Overview of attention for article published in BMC Cancer, July 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,230 followers.

Tumour shrinkage predicts favorable outcome in study of gemcitabine & oxaliplatin in biliary tract #cancer http://t.co/rsURjipE5d #PCR

Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine a... http://t.co/zxTNdf6SPV #cancer

◈ Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and... http://t.co/yI7BX1DBud ◈

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.